{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:52:40Z","timestamp":1778637160479,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007231","name":"Cancerf\u00f6reningen i Stockholm","doi-asserted-by":"publisher","award":["181263"],"award-info":[{"award-number":["181263"]}],"id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","award":["419"],"award-info":[{"award-number":["419"]}],"id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","award":["CAN2018"],"award-info":[{"award-number":["CAN2018"]}],"id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jcyt.2022.10.004","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T12:53:29Z","timestamp":1667307209000},"page":"68-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunomodulation by placenta-derived decidua stromal cells. Role of histocompatibility, accessory cells and freeze\u2013thawing"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8721-0400","authenticated-orcid":false,"given":"Behnam","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myr\u00e8se","family":"Witkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Schefberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Arbman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olle","family":"Ringd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcyt.2022.10.004_bib0001","first-page":"393","article-title":"The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Tissue Kinet"},{"issue":"8","key":"10.1016\/j.jcyt.2022.10.004_bib0002","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1182\/blood.V98.8.2396","article-title":"Identification of mesenchymal stem\/progenitor cells in human first-trimester fetal blood, liver, and bone marrow","volume":"98","author":"Campagnoli","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2022.10.004_bib0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.molmed.2018.12.006","article-title":"Intravascular Mesenchymal Stromal\/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines","volume":"25","author":"Moll","year":"2019","journal-title":"Trends Mol Med"},{"issue":"10","key":"10.1016\/j.jcyt.2022.10.004_bib0004","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.jcyt.2022.10.004_bib0005","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3026(15)00224-0","article-title":"Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis","volume":"3","author":"Hashmi","year":"2016","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.jcyt.2022.10.004_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-15-39","article-title":"Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study","volume":"15","author":"Zheng","year":"2014","journal-title":"Respir Res"},{"issue":"22","key":"10.1016\/j.jcyt.2022.10.004_bib0007","doi-asserted-by":"crossref","first-page":"10554","DOI":"10.1111\/jcmm.16986","article-title":"Conquering the cytokine storm in COVID-19-induced ARDS using placenta-derived decidua stromal cells","volume":"25","author":"Sadeghi","year":"2021","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.jcyt.2022.10.004_bib0008","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s13287-021-02635-9","article-title":"Clinical application of mesenchymal stem cells in rheumatic diseases","volume":"12","author":"Wang","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2022.10.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-021-08892-z","article-title":"Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis","author":"Zhuang","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jcyt.2022.10.004_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.839844","article-title":"Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome","volume":"13","author":"Ringden","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2022.10.004_bib0011","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp Hematol"},{"issue":"3","key":"10.1016\/j.jcyt.2022.10.004_bib0012","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2249.2011.04540.x","article-title":"Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro","volume":"167","author":"Karlsson","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.jcyt.2022.10.004_bib0013","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.179.5.2824","article-title":"The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells","volume":"179","author":"Jones","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jcyt.2022.10.004_bib0014","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/1744666X.2.3.457","article-title":"Immune cells and molecules in pregnancy: friends or foes to the fetus?","volume":"2","author":"Mincheva-Nilsson","year":"2006","journal-title":"Expert Rev Clin Immunol"},{"issue":"12","key":"10.1016\/j.jcyt.2022.10.004_bib0015","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jcyt.2015.09.001","article-title":"Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo","volume":"17","author":"Sadeghi","year":"2015","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jcyt.2022.10.004_bib0016","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/sctm.17-0167","article-title":"Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease","volume":"7","author":"Ringden","year":"2018","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"10.1016\/j.jcyt.2022.10.004_bib0017","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/stem.1314","article-title":"Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease","volume":"31","author":"Ringden","year":"2013","journal-title":"Stem Cells"},{"issue":"19","key":"10.1016\/j.jcyt.2022.10.004_bib0018","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1089\/scd.2013.0079","article-title":"Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner","volume":"22","author":"Erkers","year":"2013","journal-title":"Stem Cells Dev"},{"issue":"19","key":"10.1016\/j.jcyt.2022.10.004_bib0019","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1089\/scd.2015.0120","article-title":"Different Procoagulant Activity of Therapeutic Mesenchymal Stromal Cells Derived from Bone Marrow and Placental Decidua","volume":"24","author":"Moll","year":"2015","journal-title":"Stem Cells Dev"},{"issue":"101","key":"10.1016\/j.jcyt.2022.10.004_bib0020","first-page":"223","article-title":"Growth kinetic comparison of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue and Decidua","volume":"24","author":"Kazemi","year":"2020","journal-title":"Med Sci"},{"issue":"3","key":"10.1016\/j.jcyt.2022.10.004_bib0021","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.gastro.2010.10.013","article-title":"Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes","volume":"140","author":"Parekkadan","year":"2011","journal-title":"Gastroenterology"},{"issue":"416","key":"10.1016\/j.jcyt.2022.10.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.jcyt.2022.10.004_bib0023","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/scd.2015.0329","article-title":"Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression","volume":"25","author":"Hoogduijn","year":"2016","journal-title":"Stem Cells Dev"},{"issue":"9","key":"10.1016\/j.jcyt.2022.10.004_bib0024","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/stem.2415","article-title":"Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFN\u03b3 Licensing","volume":"34","author":"Chinnadurai","year":"2016","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.jcyt.2022.10.004_bib0025","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/stem.1729","article-title":"Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?","volume":"32","author":"Moll","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2022.10.004_bib0026","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fimmu.2020.00243","article-title":"Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies","volume":"11","author":"Moll","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.jcyt.2022.10.004_bib0027","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2022.10.004_bib0028","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Ko\u00e7","year":"2000","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jcyt.2022.10.004_bib0029","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients","volume":"11","author":"Lazarus","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jcyt.2022.10.004_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-3083.2003.01176.x","article-title":"Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex","volume":"57","author":"Le Blanc","year":"2003","journal-title":"Scand J Immunol"},{"issue":"9419","key":"10.1016\/j.jcyt.2022.10.004_bib0031","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"issue":"9624","key":"10.1016\/j.jcyt.2022.10.004_bib0032","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jcyt.2022.10.004_bib0033","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.bbmt.2009.12.057","article-title":"Prochymal Improves Response Rates In Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-GVHD) Involving The Liver And Gut: Results Of A Randomized, Placebo-Controlled, Multicenter Phase III Trial In GVHD","volume":"16","author":"Martin","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jcyt.2022.10.004_bib0034","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.bbmt.2019.08.029","article-title":"A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease","volume":"26","author":"Kebriaei","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jcyt.2022.10.004_bib0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000485735","article-title":"Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation","volume":"139","author":"Aronsson-Kurttila","year":"2018","journal-title":"Acta Haematol"},{"issue":"12","key":"10.1016\/j.jcyt.2022.10.004_bib0036","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1089\/scd.2014.0568","article-title":"Immunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patients","volume":"24","author":"Kaipe","year":"2015","journal-title":"Stem Cells Dev"},{"issue":"5","key":"10.1016\/j.jcyt.2022.10.004_bib0037","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","article-title":"Innate immune response in Th1- and Th2-dominant mouse strains","volume":"22","author":"Watanabe","year":"2004","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.jcyt.2022.10.004_bib0038","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J Orthop Res"},{"issue":"9","key":"10.1016\/j.jcyt.2022.10.004_bib0039","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/stem.3380","article-title":"Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativity","volume":"39","author":"Galipeau","year":"2021","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.jcyt.2022.10.004_bib0040","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.exphem.2009.09.004","article-title":"Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages","volume":"37","author":"Kim","year":"2009","journal-title":"Exp Hematol"},{"issue":"4","key":"10.1016\/j.jcyt.2022.10.004_bib0041","doi-asserted-by":"crossref","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","article-title":"A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype","volume":"5","author":"Waterman","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jcyt.2022.10.004_bib0042","doi-asserted-by":"crossref","first-page":"e9252","DOI":"10.1371\/journal.pone.0009252","article-title":"Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile","volume":"5","author":"Maggini","year":"2010","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jcyt.2022.10.004_bib0043","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2022.10.004_bib0044","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.smim.2018.01.002","article-title":"Mesenchymal-myeloid interaction in the regulation of immunity","volume":"35","author":"Cheung","year":"2018","journal-title":"Semin Immunol"},{"issue":"7","key":"10.1016\/j.jcyt.2022.10.004_bib0045","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/stem.2369","article-title":"Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses","volume":"34","author":"Chiossone","year":"2016","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.jcyt.2022.10.004_bib0046","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/stem.2344","article-title":"Mesenchymal Stem Cells Induce Suppressive Macrophages Through Phagocytosis in a Mouse Model of Asthma","volume":"34","author":"Braza","year":"2016","journal-title":"Stem Cells,"},{"issue":"6","key":"10.1016\/j.jcyt.2022.10.004_bib0047","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2012.078055","article-title":"Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6","volume":"98","author":"Melief","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.jcyt.2022.10.004_bib0048","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2022.10.004_bib0049","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fimmu.2017.00465","article-title":"Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation","volume":"8","author":"Simonetta","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2022.10.004_bib0050","doi-asserted-by":"crossref","unstructured":"Barrett, A.J., Understanding and harnessing the graft-versus-leukaemia effect. 2008. 142(6): p. 877-888.","DOI":"10.1111\/j.1365-2141.2008.07260.x"},{"issue":"1","key":"10.1016\/j.jcyt.2022.10.004_bib0051","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13287-021-02277-x","article-title":"Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future","volume":"12","author":"Lamb","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.jcyt.2022.10.004_bib0052","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/14653249.2011.623691","article-title":"Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-\u03b3 licensing","volume":"14","author":"Fran\u00e7ois","year":"2012","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.jcyt.2022.10.004_bib0053","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yexcr.2004.12.013","article-title":"Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms","volume":"305","author":"Rasmusson","year":"2005","journal-title":"Exp Cell Res"},{"issue":"7","key":"10.1016\/j.jcyt.2022.10.004_bib0054","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/term.109","article-title":"Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation","volume":"2","author":"Pal","year":"2008","journal-title":"J Tissue Eng Regen Med"},{"issue":"7","key":"10.1016\/j.jcyt.2022.10.004_bib0055","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1537-2995.2009.02138.x","article-title":"Liquid storage of marrow stromal cells","volume":"49","author":"Lane","year":"2009","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.jcyt.2022.10.004_bib0056","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3727\/096368912X657602","article-title":"Effects of storage solutions on the viability of human umbilical cord mesenchymal stem cells for transplantation","volume":"22","author":"Chen","year":"2013","journal-title":"Cell Transplant"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922008283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922008283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T23:37:43Z","timestamp":1672270663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324922008283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1465324922008283"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.10.004","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulation by placenta-derived decidua stromal cells. Role of histocompatibility, accessory cells and freeze\u2013thawing","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}